News

The Magnificent Seven declined on Monday, capping off the worst month and quarter on record for the group of big tech stocks that account for more than a quarter of the S&P 500's market value.

One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year.

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of reciprocal tariffs later this week.

NEW YORK (Reuters) -As Wall Street draws the curtain on a tumultuous quarter in which stocks logged a record high before tumbling into correction, investors are faced with a mountain of policy uncertainty that clouds the outlook for coming quarters. The S&P 500 Index finished the quarter down 4.6%, its worst first three months of a year since the first quarter of 2022. Investors, who started the year with high hopes for pro-growth policies from the Trump administration, have been spooked by a barrage of tariff-related headlines.

NEW YORK (Reuters) -New York Federal Reserve President John Williams said on Monday that monetary policy is "well positioned" for what the economy might do this year, as he acknowledged there are risks that inflation could once again heat up. "Monetary policy is moderately restrictive," Williams said in an interview with Yahoo Finance, with the current setting of interest rates "putting some downward pressure on inflation." Williams added that while he cannot predict when the U.S. central bank might change the current level of interest rates, keeping it in place "for some time" will allow officials to study incoming data and decide what they need to do next.

Fashion conglomerate PVH (NYSE:PVH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 4.8% year on year to $2.37 billion. Its non-GAAP profit of $3.27 per share was 1.8% above analysts’ consensus estimates.

(Bloomberg) -- Shares of Coinbase Global Inc. and other firms linked to cryptocurrencies were hammered this quarter as growing concerns about the US economy weighed on digital assets. Most Read from BloombergGold-Rush Fever Returns to Historic New Zealand Mining TownWhat Frank Lloyd Wright Learned From the DesertBank Regulators Fight for Desks as OCC Returns to New York TowerCoinbase fell 31% in the worst quarterly performance since FTX collapsed near the end of 2022. Nearly every major crypto-l

Shares of energy drink company Celsius (NASDAQ:CELH) jumped 8.9% in the afternoon session after Truist analysts upgraded the stock's rating from Hold to Buy and raised the price target from $35 to $45. The analysts added, "In our opinion, the market is already looking past the hiccups of the legacy business in 2024 and the brand's slowdown in 1Q25."

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 12.5% in the morning session after Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research (CBER), resigned on Friday, 28 March 2025. Marks noted his departure was related to "misinformation and lies" around immunization and raised concerns about the Trump administration's ability to "swiftly approve critical vaccines."

As Wall Street heads into a new quarter, a flurry of President Donald Trump’s tariffs are set to go into effect. That has traders on edge and has helped put US stocks in their worst first-quarter slump in years.